Search research articles
Contact Us
Filters
Showing results (81-90 of 185) with videos related to
Page
of 19
Sort By:
The Australasian Journal of Dermatology
|
November 17, 2025
Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies
Conor Larney, Philip Lee, Zachary Holmes, et al.
The Australasian Journal of Dermatology
|
July 11, 2022
Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study
Peter Foley, Lynda Spelman, Dedee F Murrell, et al.
The Journal of Dermatological Treatment
|
May 11, 2017
Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population
Diana Norris, Louise Photiou, Mark Tacey, et al.
BMC Infectious Diseases
|
January 9, 2020
Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis
Maria Stavrou, Jing Ming Yeo, Alexander David Slater, et al.
International Journal of Dermatology
|
November 26, 2009
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program
Peter Foley, Michael Freeman, Kurt Gebauer, et al.
Journal of Drugs in Dermatology : JDD
|
December 3, 2011
A comparison of cryotherapy and imiquimod for treatment of actinic keratoses: lesion clearance, safety, and skin quality outcomes
Peter Foley, Kate Merlin, Simon Cumming, et al.
The Australasian Journal of Dermatology
|
January 18, 2026
Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative Review
Diana Rubel, Peter Foley, Kathryn A Gibson, et al.
The Australasian Journal of Dermatology
|
July 9, 2022
Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21-month analysis in Australian routine clinical practice (SUSTAIN study)
Peter Foley, Nick Manuelpillai, Con Dolianitis, et al.
Practical Neurology
|
August 8, 2012
Lesley's story: a case report, and discussion of challenges faced in end-of-life care for progressive neurological disease
Peter Foley, Justine Hampton, Andy Hampton, et al.
The Journal of Dermatological Treatment
|
July 16, 2019
Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab
Kristian Reich, Peter Foley, Chenglong Han, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 185) with videos related to
Sort By:
Page
of 19
The Australasian Journal of Dermatology
|
November 17, 2025
Shedding Light on Actinic Prurigo: A Systematic Review of Emerging Therapies
Conor Larney, Philip Lee, Zachary Holmes, et al.
The Australasian Journal of Dermatology
|
July 11, 2022
Secukinumab treatment showed improved quality of life in patients with chronic plaque psoriasis in Australia: Results from the HOPE study
Peter Foley, Lynda Spelman, Dedee F Murrell, et al.
The Journal of Dermatological Treatment
|
May 11, 2017
Biologics and dermatology life quality index (DLQI) in the Australasian psoriasis population
Diana Norris, Louise Photiou, Mark Tacey, et al.
BMC Infectious Diseases
|
January 9, 2020
Case report: meningitis as a presenting feature of anti-NMDA receptor encephalitis
Maria Stavrou, Jing Ming Yeo, Alexander David Slater, et al.
International Journal of Dermatology
|
November 26, 2009
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program
Peter Foley, Michael Freeman, Kurt Gebauer, et al.
Journal of Drugs in Dermatology : JDD
|
December 3, 2011
A comparison of cryotherapy and imiquimod for treatment of actinic keratoses: lesion clearance, safety, and skin quality outcomes
Peter Foley, Kate Merlin, Simon Cumming, et al.
The Australasian Journal of Dermatology
|
January 18, 2026
Targeted Systemic Therapies for Atopic Dermatitis in Australia: A Narrative Review
Diana Rubel, Peter Foley, Kathryn A Gibson, et al.
The Australasian Journal of Dermatology
|
July 9, 2022
Secukinumab treatment demonstrated high drug survival and sustained effectiveness in patients with severe chronic plaque psoriasis: 21-month analysis in Australian routine clinical practice (SUSTAIN study)
Peter Foley, Nick Manuelpillai, Con Dolianitis, et al.
Practical Neurology
|
August 8, 2012
Lesley's story: a case report, and discussion of challenges faced in end-of-life care for progressive neurological disease
Peter Foley, Justine Hampton, Andy Hampton, et al.
The Journal of Dermatological Treatment
|
July 16, 2019
Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab
Kristian Reich, Peter Foley, Chenglong Han, et al.
Page
of 19